AQR Capital Management Portfolio holdings
AUM
$121B
1-Year Return
23.38%
This Quarter Return
-1.38%
1 Year Return
+23.38%
3 Year Return
+85.44%
5 Year Return
+156.19%
10 Year Return
+370.97%
AUM
$97.1B
AUM Growth
+$19.4B
(+25%)
Cap. Flow
+$22.6B
Cap. Flow
% of AUM
23.3%
Top 10 Holdings %
Top 10 Hldgs %
12.02%
Holding
3,234
New
373
Increased
1,829
Reduced
905
Closed
84
Top Buys
| 1 |
General Motors
GM
|
+$374M |
| 2 |
Snowflake
SNOW
|
+$354M |
| 3 |
Arista Networks
ANET
|
+$354M |
| 4 |
Roblox
RBLX
|
+$345M |
| 5 |
Adobe
ADBE
|
+$332M |
Top Sells
| 1 |
SMAR
Smartsheet Inc.
SMAR
|
+$173M |
| 2 |
Progressive
PGR
|
+$169M |
| 3 |
AbbVie
ABBV
|
+$139M |
| 4 |
Robinhood
HOOD
|
+$132M |
| 5 |
Cardinal Health
CAH
|
+$123M |
Sector Composition
| 1 | Technology | 22.14% |
| 2 | Financials | 16.12% |
| 3 | Healthcare | 13.87% |
| 4 | Consumer Discretionary | 11.39% |
| 5 | Industrials | 11.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3001
ICL Group
ICL
$7.87B
| $107K | ﹤0.01% |
+18,838
| New | +$107K |
|
3002
Evolent Health
EVH
$1.16B
| $107K | ﹤0.01% |
11,297
-657
| -5% | -$6.22K |
|
3003
Clarus
CLAR
$154M
| $106K | ﹤0.01% |
28,396
-63,631
| -69% | -$239K |
|
3004
Applied Digital
APLD
$3.98B
| $106K | ﹤0.01% |
18,945
+8,692
| +85% | +$48.8K |
|
|
TSVT
3005
DELISTED
2seventy bio
TSVT
| $106K | ﹤0.01% |
+21,417
| New | +$106K |
|
3006
Intuitive Machines
LUNR
$991M
| $105K | ﹤0.01% |
14,096
-9,522
| -40% | -$70.9K |
|
3007
Liberty Latin America Class A
LILA
$1.55B
| $104K | ﹤0.01% |
+16,469
| New | +$104K |
|
3008
Outlook Therapeutics
OTLK
$41.2M
| $103K | ﹤0.01% |
84,671
+25,351
| +43% | +$30.9K |
|
|
LGF.B
3009
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $103K | ﹤0.01% |
+13,040
| New | +$103K |
|
3010
BlackSky Technology
BKSY
$579M
| $103K | ﹤0.01% |
+13,358
| New | +$103K |
|
3011
PubMatic
PUBM
$389M
| $103K | ﹤0.01% |
11,268
-1,980
| -15% | -$18.1K |
|
3012
Cabaletta Bio
CABA
$150M
| $102K | ﹤0.01% |
+73,956
| New | +$102K |
|
3013
Actinium Pharmaceuticals
ATNM
$49.9M
| $102K | ﹤0.01% |
63,249
+46,545
| +279% | +$74.9K |
|
3014
FTAI Infrastructure
FIP
$460M
| $101K | ﹤0.01% |
22,238
-7,351
| -25% | -$33.3K |
|
3015
Theravance Biopharma
TBPH
$693M
| $101K | ﹤0.01% |
+11,270
| New | +$101K |
|
3016
Grifois
GRFS
$6.72B
| $98.9K | ﹤0.01% |
13,916
-3,512
| -20% | -$25K |
|
3017
Pliant Therapeutics
PLRX
$107M
| $97.3K | ﹤0.01% |
+72,057
| New | +$97.3K |
|
3018
Star Holdings Shares of Beneficial Interest
STHO
$117M
| $96.4K | ﹤0.01% |
+11,331
| New | +$96.4K |
|
|
LGF.A
3019
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $95.8K | ﹤0.01% |
+11,057
| New | +$95.8K |
|
3020
Mercer International
MERC
$214M
| $95.6K | ﹤0.01% |
+15,538
| New | +$95.6K |
|
3021
TrueCar
TRUE
$190M
| $94.5K | ﹤0.01% |
59,791
+45,980
| +333% | +$72.6K |
|
3022
Kaltura
KLTR
$233M
| $94.4K | ﹤0.01% |
50,234
+25,083
| +100% | +$47.2K |
|
3023
Precigen
PGEN
$1.23B
| $94.1K | ﹤0.01% |
63,179
+43,245
| +217% | +$64.4K |
|
3024
Lyell Immunopharma
LYEL
$253M
| $93.8K | ﹤0.01% |
8,714
+7,716
| +773% | +$83K |
|
3025
Cardiff Oncology
CRDF
$142M
| $91.6K | ﹤0.01% |
29,183
-11,456
| -28% | -$36K |
|